Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;35(3):197-202.
doi: 10.4103/0971-5851.142032.

Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies

Sharlene Gill  1
Affiliations

Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies

Sharlene Gill. Indian J Med Paediatr Oncol. 2014 Jul.

Abstract

This evidence-based review will discuss the current standard of adjuvant chemotherapy for resected high-risk colon cancer and address existing controversies including strategies for risk-stratification, the status of targeted therapy, treatment of the elderly and the optimal duration of therapy.

Keywords: 5-FU; Adjuvant therapy; colon cancer; oxaliplatin; stage II.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN. 1.0. Lyon, France: International Agency for Research on Cancer; 2012. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] Available from http://globocan.iarc.fr .
    1. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352–8. - PubMed
    1. Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham DL, et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes’ B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol. 1999;17:3553–9. - PubMed
    1. Haller DG, Catalano PJ, Macdonald JS, O’Rourke MA, Frontiera MS, Jackson DV, et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: Final report of Intergroup 0089. J Clin Oncol. 2005;23:8671–8. - PubMed
    1. André T, Quinaux E, Louvet C, Colin P, Gamelin E, Bouche O, et al. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: Final results of GERCOR C96.1. J Clin Oncol. 2007;25:3732–8. - PubMed